Multiple vaccine manufacturers are currently developing COVID-19 vaccines for children less than 12 years old.
An Emergency Use Authorization (EUA) application for the Pfizer-BioNTech COVID-19 Vaccine for children 5-11 years old has been submitted to the FDA and may receive authorization before other vaccines. This document outlines what is currently known and some assumptions to inform jurisdictional planning of a COVID-19 vaccination program for children less than12 years old, pending FDA authorization and Advisory Committee on Immunization Practices (ACIP) recommendations. Some details about the vaccination program are still pending and additional information will be forthcoming.
What is currently known about COVID-19 vaccines for children less than 12 years old: